{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T15:51:58Z","timestamp":1792857118334,"version":"4.5.0"},"reference-count":97,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T00:00:00Z","timestamp":1555027200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100007787","name":"National Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007787","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Biochem Biotechnol"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s12010-019-02995-2","type":"journal-article","created":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T01:02:33Z","timestamp":1555030953000},"page":"284-304","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Mesenchymal Stem Cells: a Promising Therapeutic Tool for Acute Kidney Injury"],"prefix":"10.1007","volume":"189","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0643-462X","authenticated-orcid":false,"given":"Rehab E.","family":"Selim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanaa H.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somia H.","family":"Abd-Allah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilane M.","family":"Sabry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasha E.","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wagdy K. B.","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nehal S.","family":"Abouhashem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,12]]},"reference":[{"key":"2995_CR1","first-page":"14","volume":"13","author":"PK Moore","year":"2018","unstructured":"Moore, P. K., Hsu, R. K., & Liu, K. D. (2018). Management of acute kidney injury: core curriculum. American Journal of Kidney Diseases, 13, 14\u201315.","journal-title":"American Journal of Kidney Diseases"},{"issue":"9843","key":"2995_CR2","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/S0140-6736(11)61454-2","volume":"380","author":"R Bellomo","year":"2012","unstructured":"Bellomo, R., Kellum, J. A., & Ronco, C. (2012). Acute kidney injury. The Lancet, 380(9843), 756\u2013766.","journal-title":"The Lancet"},{"key":"2995_CR3","doi-asserted-by":"crossref","unstructured":"Ve\u010deri\u0107-Haler, \u017d., Cerar, A., and Per\u0161e, M. (2017). (Mesenchymal) stem cell-based therapy in cisplatin-induced acute kidney injury animal model: risk of immunogenicity and tumorigenicity. Stem Cells International, 2017.","DOI":"10.1155\/2017\/7304643"},{"issue":"4","key":"2995_CR4","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1093\/ndt\/gfs556","volume":"28","author":"M Morigi","year":"2013","unstructured":"Morigi, M., & Benigni, A. (2013). Mesenchymal stem cells and kidney repair. Nephrology, Dialysis, Transplantation, 28(4), 788\u2013793.","journal-title":"Nephrology, Dialysis, Transplantation"},{"key":"2995_CR5","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/stem.293","volume":"28","author":"M Morigi","year":"2010","unstructured":"Morigi, M., Rota, C., Montemurro, T., Cicero, V. L., Imberti, B., Abbate, M., Zoia, C., Cassis, P., Longaretti, L., Rebulla, P., Introna, M., Capelli, C., Benigni, A., Remuzzi, G., & Lazzari, L. (2010). Life-sparing effect of human cord blood-mesenchymal stem cells in experimental acute kidney injury. Stem Cells, 28, 513\u2013522.","journal-title":"Stem Cells"},{"issue":"1","key":"2995_CR6","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/1479-5876-9-51","volume":"9","author":"YT Chen","year":"2011","unstructured":"Chen, Y. T., Sun, C. K., Lin, Y. C., Chang, L. T., Chen, Y. L., Tsai, T. H., Chung, S. Y., Chua, S., Kao, Y. H., Yen, C. H., Shao, P. L., Chang, K. C., Leu, S., & Yip, H. K. (2011). Adipose-derived mesenchymal stem cell protects kidneys against ischemia-reperfusion injury through suppressing oxidative stress and inflammatory reaction. Journal of Translational Medicine, 9(1), 51.","journal-title":"Journal of Translational Medicine"},{"issue":"4","key":"2995_CR7","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1093\/abbs\/gmx016","volume":"49","author":"X Liu","year":"2017","unstructured":"Liu, X., Cai, J., Jiao, X., Yu, X., & Ding, X. (2017). Therapeutic potential of mesenchymal stem cells in acute kidney injury is affected by administration timing. Acta Biochimica et Biophysica Sinica, 49(4), 338\u2013348.","journal-title":"Acta Biochimica et Biophysica Sinica"},{"issue":"1-4","key":"2995_CR8","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1159\/000363680","volume":"127","author":"V Fleig","year":"2014","unstructured":"Fleig, V., & Humphreys, B. D. (2014). Rationale of mesenchymal stem cell therapy in kidney injury. Nephron. Clinical Practice, 127(1-4), 75\u201380.","journal-title":"Nephron. Clinical Practice"},{"issue":"5-6","key":"2995_CR9","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.cytogfr.2009.10.002","volume":"20","author":"LDAS Meirelles","year":"2009","unstructured":"Meirelles, L. D. A. S., Fontes, A. M., Covas, D. T., & Caplan, A. I. (2009). Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine & Growth Factor Reviews, 20(5-6), 419\u2013427.","journal-title":"Cytokine & Growth Factor Reviews"},{"issue":"2","key":"2995_CR10","doi-asserted-by":"publisher","first-page":"162","DOI":"10.3109\/14653249.2011.613927","volume":"14","author":"H Liu","year":"2012","unstructured":"Liu, H., McTaggart, S. J., Johnson, D. W., & Gobe, G. C. (2012). Original article anti-oxidant pathways are stimulated by mesenchymal stromal cells in renal repair after ischemic injury. Cytotherapy, 14(2), 162\u2013172.","journal-title":"Cytotherapy"},{"issue":"3","key":"2995_CR11","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.mvr.2007.11.007","volume":"75","author":"L Sanz","year":"2008","unstructured":"Sanz, L., Santos-Valle, P., Alonso-Camino, V., Salas, C., Serrano, A., Vicario, J. L., Cuesta, M. A., Compte, M., S\u00e1nchez-Mart\u00edn, D., & \u00c1lvarez-Vallina, L. (2008). Long-term in vivo imaging of human angiogenesis: critical role of bone marrow derived mesenchymal stem cells for the generation of durable blood vessels. Microvascular Research, 75(3), 308\u2013314.","journal-title":"Microvascular Research"},{"issue":"11","key":"2995_CR12","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1016\/j.exphem.2006.07.015","volume":"34","author":"DP Lennon","year":"2006","unstructured":"Lennon, D. P., & Caplan, A. I. (2006). Isolation of rat marrow-derived mesenchymal stem cells. Experimental Hematology, 34(11), 1606\u20131607.","journal-title":"Experimental Hematology"},{"issue":"1","key":"2995_CR13","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1093\/toxsci\/kfp222","volume":"113","author":"A Nemmar","year":"2010","unstructured":"Nemmar, A., Al-Salam, S., Zia, S., Yasin, J., Al Husseni, I., & Ali, B. H. (2010). Diesel exhaust particles in the lung aggravate experimental acute renal failure. Toxicological Sciences, 113(1), 267\u2013277.","journal-title":"Toxicological Sciences"},{"issue":"2","key":"2995_CR14","doi-asserted-by":"publisher","first-page":"468","DOI":"10.3892\/etm.2015.2505","volume":"10","author":"W Yao","year":"2015","unstructured":"Yao, W., Hu, Q., Ma, Y., Xiong, W., Wu, T., Cao, J., & Wu, D. (2015). Human adipose-derived mesenchymal stem cells repair cisplatin-induced acute kidney injury through antiapoptotic pathways. Experimental and Therapeutic Medicine, 10(2), 468\u2013476.","journal-title":"Experimental and Therapeutic Medicine"},{"key":"2995_CR15","unstructured":"Rastghalam, R., M. Nematbakhsh, M. Bahadorani, F. Eshraghi-Jazi, A. Talebi, M. Moeini, F. Ashrafi, S. Shirdavani (2014) Angiotensin type-1 receptor blockade may not protect kidney against cisplatin-induced nephrotoxicity in rats. Nephrology 2014."},{"key":"2995_CR16","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.3892\/ijmm.2013.1517","volume":"32","author":"QI Shaohua","year":"2013","unstructured":"Shaohua, Q. I., & Dongcheng, W. U. (2013). Bone marrow-derived mesenchymal stem cells protect against cisplatin-induced acute kidney injury in rats by inhibiting cell apoptosis. International Journal of Molecular Medicine, 32, 1262\u20131272.","journal-title":"International Journal of Molecular Medicine"},{"key":"2995_CR17","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1152\/ajprenal.00339.2006","volume":"292","author":"F T\u00f6gel","year":"2007","unstructured":"T\u00f6gel, F., Weiss, K., Yang, Y., Hu, Z., Zhang, P., & Westenfelder, C. (2007). Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury. American Journal of Physiology. Renal Physiology, 292, 1626\u20131635.","journal-title":"American Journal of Physiology. Renal Physiology"},{"issue":"2","key":"2995_CR18","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1053\/jhep.2000.9109","volume":"32","author":"T Nakamura","year":"2000","unstructured":"Nakamura, T., Sakata, R., Ueno, T., Sata, M., & Ueno, H. (2000). Inhibition of transforming growth factor beta prevents progression of liver fibrosis and enhances hepatocyte regeneration in dimethyl nitrosamine-treated rats. Hepatology, 32(2), 247\u2013255.","journal-title":"Hepatology"},{"key":"2995_CR19","first-page":"433","volume-title":"Theory and practice of histological techniques. 6th Ed.","author":"JD Bancroft","year":"2008","unstructured":"Bancroft, J. D., & Gamble, M. (2008). Theory and practice of histological techniques. 6th Ed. (pp. 433\u2013469). Philadelphia: Churchill Livingstone-Elsevier."},{"issue":"4","key":"2995_CR20","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1007\/s12010-017-2631-0","volume":"184","author":"MM Elseweidy","year":"2018","unstructured":"Elseweidy, M. M., Askar, M. E., Elswefy, S. E., & Shawky, M. (2018). Nephrotoxicity induced by cisplatin intake in experimental rats and therapeutic approach of using mesenchymal stem cells and spironolactone. Applied Biochemistry and Biotechnology, 184(4), 1390\u20131403.","journal-title":"Applied Biochemistry and Biotechnology"},{"key":"2995_CR21","doi-asserted-by":"crossref","unstructured":"Ozkok, A., C.L. Edelstein (2014) Pathophysiology of cisplatin-induced acute kidney injury. BioMed Research International, 2014.","DOI":"10.1155\/2014\/967826"},{"issue":"8","key":"2995_CR22","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1248\/bpb.28.1385","volume":"28","author":"Y Kawai","year":"2005","unstructured":"Kawai, Y., Taniuchi, S., Okahara, S., Nakamura, M., & Gemba, M. (2005). Relationship between cisplatin or nedaplatin-induced nephrotoxicity and renal accumulation. Biological & Pharmaceutical Bulletin, 28(8), 1385\u20131388.","journal-title":"Biological & Pharmaceutical Bulletin"},{"issue":"4","key":"2995_CR23","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/clpt.2009.139","volume":"86","author":"KK Filipski","year":"2009","unstructured":"Filipski, K. K., Mathijssen, R. H., Mikkelsen, T. S., Schinkel, A. H., & Sparreboom, A. (2009). Contribution of organic cation transporter 2 (OCT2) to cisplatin-induced nephrotoxicity. Clinical Pharmacology and Therapeutics, 86(4), 396\u2013402.","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"5","key":"2995_CR24","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/S0270-9295(03)00089-5","volume":"23","author":"I Arany","year":"2003","unstructured":"Arany, I., & Safirstein, R. L. (2003). Cisplatin nephrotoxicity. Seminars in Nephrology, 23(5), 460\u2013464.","journal-title":"Seminars in Nephrology"},{"issue":"4","key":"2995_CR25","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1681\/ASN.V24856","volume":"2","author":"SW Lew","year":"1991","unstructured":"Lew, S. W., & Bosch, J. P. (1991). Effect of diet on creatinine clearance and excretion in young and elderly healthy subjects and in patients with renal disease. Journal of the American Society of Nephrology, 2(4), 856\u2013865.","journal-title":"Journal of the American Society of Nephrology"},{"key":"2995_CR26","first-page":"F79","volume":"274","author":"J Kontogiannis","year":"1998","unstructured":"Kontogiannis, J., & Burns, K. D. (1998). Role of AT1 angiotensin II receptors in renal ischemic injury. The American Journal of Physiology, 274, F79\u2013F90.","journal-title":"The American Journal of Physiology"},{"key":"2995_CR27","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1001\/archinte.160.5.685","volume":"160","author":"G Bakris","year":"2000","unstructured":"Bakris, G., & Weir, M. (2000). Angiotensin converting enzyme inhibitor-associated elevations in serum creatinine. Is a cause for cancer? Archives of Internal Medicine, 160, 685\u2013693.","journal-title":"Archives of Internal Medicine"},{"issue":"5","key":"2995_CR28","doi-asserted-by":"publisher","first-page":"644","DOI":"10.4252\/wjsc.v6.i5.644","volume":"6","author":"F Bianchi","year":"2014","unstructured":"Bianchi, F., Sala, E., Donadei, C., Capelli, I., & La Manna, G. (2014). Potential advantages of acute kidney injury management by mesenchymal stem cells. World Journal of Stem Cells, 6(5), 644\u2013650.","journal-title":"World Journal of Stem Cells"},{"issue":"7","key":"2995_CR29","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1097\/01.ASN.0000128974.07460.34","volume":"15","author":"M Morigi","year":"2004","unstructured":"Morigi, M., Imberti, B., Zoja, C., Corna, D., Tomasoni, S., Abbate, M., Rottoli, D., Angioletti, S., Benigni, A., Perico, N., Alison, M., & Remuzzi, G. (2004). Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure. Journal of the American Society of Nephrology, 15(7), 1794\u20131804.","journal-title":"Journal of the American Society of Nephrology"},{"issue":"5","key":"2995_CR30","doi-asserted-by":"publisher","first-page":"e0154451","DOI":"10.1371\/journal.pone.0154451","volume":"11","author":"I Bancu","year":"2016","unstructured":"Bancu, I., D\u00edaz, M. N., Serra, A., Granada, M., Lopez, D., Romero, R., & Bonet, J. (2016). Low insulin-like growth factor-1 level in obesity nephropathy: a new risk factor? PLoS One, 11(5), e0154451.","journal-title":"PLoS One"},{"issue":"1","key":"2995_CR31","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1146\/annurev.physiol.65.092101.142638","volume":"65","author":"JM Sands","year":"2003","unstructured":"Sands, J. M. (2003). Mammalian urea transporters. Annual Review of Physiology, 65(1), 543\u2013566.","journal-title":"Annual Review of Physiology"},{"issue":"5","key":"2995_CR32","doi-asserted-by":"publisher","first-page":"F881","DOI":"10.1152\/ajprenal.00367.2004","volume":"288","author":"B Yang","year":"2005","unstructured":"Yang, B., & Bankir, L. (2005). Urea and urine concentrating ability: new insights from studies in mice. American Journal of Physiology. Renal Physiology, 288(5), F881\u2013F896.","journal-title":"American Journal of Physiology. Renal Physiology"},{"issue":"5","key":"2995_CR33","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1007\/s00134-002-1264-z","volume":"28","author":"M Bucher","year":"2002","unstructured":"Bucher, M., & Taeger, K. (2002). Endothelin-receptor gene-expression in rat endotoxemia. Intensive Care Medicine, 28(5), 642\u2013647.","journal-title":"Intensive Care Medicine"},{"issue":"2","key":"2995_CR34","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1097\/01.CCM.0000048621.36569.69","volume":"31","author":"M Bucher","year":"2003","unstructured":"Bucher, M., Kees, F., Taeger, K., & Kurtz, A. (2003). Cytokines down-regulate alpha1-adrenergic receptor expression during endotoxemia. Critical Care Medicine, 31(2), 566\u2013571.","journal-title":"Critical Care Medicine"},{"issue":"3","key":"2995_CR35","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1681\/ASN.2005010102","volume":"17","author":"M Liu","year":"2006","unstructured":"Liu, M., Chien, C. C., Burne-Taney, M., Molls, R. R., Racusen, L. C., Colvin, R. B., & Rabb, H. (2006). A pathophysiologic role for T lymphocytes in murine acute cisplatin nephrotoxicity. Journal of the American Society of Nephrology, 17(3), 765\u2013774.","journal-title":"Journal of the American Society of Nephrology"},{"issue":"3","key":"2995_CR36","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1515\/acve-2016-0033","volume":"66","author":"M Ivanov","year":"2016","unstructured":"Ivanov, M., Mihailovi\u0107-Stanojevi\u0107, N., Markovi\u0107-Lipkovski, J., Jovovi\u0107, \u0110., Karanovi\u0107, D., Miloradovi\u0107, Z., & Gruji\u0107-Milanovi\u0107, J. (2016). Combined angiotensin II type-1 receptor blockade and superoxide anion scavenging affect the post-ischemic kidney in hypertensive rats. Acta Veterinaria, 66(3), 392\u2013405.","journal-title":"Acta Veterinaria"},{"issue":"1","key":"2995_CR37","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1254\/jphs.FP0050661","volume":"100","author":"Y Kawai","year":"2006","unstructured":"Kawai, Y., Nakao, T., Kunimura, N., Kohda, Y., & Gemba, M. (2006). Relationship of intracellular calcium and oxygen radicals to cisplatin-related renal cell injury. Journal of Pharmacological Sciences, 100(1), 65\u201372.","journal-title":"Journal of Pharmacological Sciences"},{"issue":"12","key":"2995_CR38","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1177\/1535370215577582","volume":"240","author":"IO Sherif","year":"2015","unstructured":"Sherif, I. O., Al-Mutabagani, L. A., Alnakhli, A. M., Sobh, M. A., & Mohammed, H. E. (2015). Renoprotective effects of angiotensin receptor blocker and stem cells in acute kidney injury: involvement of inflammatory and apoptotic markers. Experimental Biology and Medicine, 240(12), 1572\u20131579.","journal-title":"Experimental Biology and Medicine"},{"issue":"6","key":"2995_CR39","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1007\/s00280-012-1860-8","volume":"69","author":"M Kume","year":"2012","unstructured":"Kume, M., Yasui, H., Yoshikawa, Y., Horinouchi, M., Higashiguchi, K., Kobayashi, Y., Kuroda, D., Hirano, T., Hirai, M., & Nakamura, T. (2012). Transient elevation of serum cystatin C concentrations during perioperative cisplatin-based chemotherapy in esophageal cancer patients. Cancer Chemotherapy and Pharmacology, 69(6), 1537\u20131544.","journal-title":"Cancer Chemotherapy and Pharmacology"},{"key":"2995_CR40","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.trsl.2015.11.001","volume":"169","author":"M Purde","year":"2016","unstructured":"Purde, M., Nock, S., Risch, L., Escobar, P. M., Grebhardt, C., Nydegger, U. E., Stanga, Z., & Risch, M. (2016). The cystatin C\/creatinine ratio, a marker of glomerular filtration quality: associated factors, reference intervals, and prediction of morbidity and mortality in healthy seniors. Translational Research, 169, 80\u201390.","journal-title":"Translational Research"},{"key":"2995_CR41","first-page":"253","volume":"17","author":"K Deveci","year":"2013","unstructured":"Deveci, K., Gokakin, A. K., Senel, S., Deveci, H., Uslu, A. U., & Sancakdar, E. (2013). Cystatin C in serum as an early marker of renal involvement in familial Mediterranean fever patients. European Review for Medical and Pharmacological Sciences, 17, 253\u2013260.","journal-title":"European Review for Medical and Pharmacological Sciences"},{"issue":"2","key":"2995_CR42","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/sj.ki.5000073","volume":"69","author":"AD Rule","year":"2006","unstructured":"Rule, A. D., Bergstralh, E. J., Slezak, J. M., Bergert, J., & Larson, T. S. (2006). Glomerular filtration rate estimated by cystatin C among different clinical presentations. Kidney International, 69(2), 399\u2013405.","journal-title":"Kidney International"},{"issue":"3","key":"2995_CR43","doi-asserted-by":"publisher","first-page":"180","DOI":"10.4103\/0971-4065.111840","volume":"23","author":"MSN Murty","year":"2013","unstructured":"Murty, M. S. N., Sharma, U. K., Pandey, V. B., & Kankare, S. B. (2013). Serum cystatin C as a marker of renal function in detection of early acute kidney injury. Indian Journal of Nephrolology, 23(3), 180\u2013183.","journal-title":"Indian Journal of Nephrolology"},{"issue":"5","key":"2995_CR44","doi-asserted-by":"publisher","first-page":"766","DOI":"10.3109\/0886022X.2013.780561","volume":"35","author":"Z Wen","year":"2013","unstructured":"Wen, Z., Cai, M., Mai, Z., Chen, Y., Geng, D., & Wang, J. (2013). Protection of renal impairment by angiotensin II type 1 receptor blocker in rats with post-infarction heart failure. Renal Failure, 35(5), 766\u2013775.","journal-title":"Renal Failure"},{"issue":"6","key":"2995_CR45","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.3892\/etm.2015.2837","volume":"10","author":"Y Zhang","year":"2015","unstructured":"Zhang, Y., Li, Y., & Cheng, G. (2015). Effect of low-dose diuretics on the level of serum cystatin C and prognosis in patients with asymptomatic chronic heart failure. Experimental and Therapeutic Medicine, 10(6), 2345\u20132350.","journal-title":"Experimental and Therapeutic Medicine"},{"issue":"7","key":"2995_CR46","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1111\/nep.12812","volume":"22","author":"HH Ahmed","year":"2017","unstructured":"Ahmed, H. H., Toson, E. A., El-mezayen, H. A., Rashed, L. A., & Elsherbiny, E. S. (2017). Role of mesenchymal stem cells versus angiotensin converting enzyme inhibitor in kidney repair. Nephrology, 22(7), 531\u2013540.","journal-title":"Nephrology"},{"issue":"5","key":"2995_CR47","first-page":"761","volume":"37","author":"SS Cao","year":"2017","unstructured":"Cao, S. S., Yan, M., Hou, Z. Y., Chen, Y., Jiang, Y. S., Fan, X. R., et al. (2017). Danshen modulates Nrf2-mediated signaling pathway in cisplatin-induced renal injury. Journal of Huazhong University of Science and Technology. Medical Sciences, 37(5), 761\u2013765.","journal-title":"Journal of Huazhong University of Science and Technology. Medical Sciences"},{"issue":"3","key":"2995_CR48","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.phrs.2004.03.003","volume":"50","author":"HR Yilmaz","year":"2004","unstructured":"Yilmaz, H. R., Iraz, M., Sogut, S., Ozyurt, H., Yildirim, Z., Akyol, O., & Gergerlioglu, S. (2004). The effects of erdosteine on the activities of some metabolic enzymes during cisplatin-induced nephrotoxicity in rats. Pharmacological Research, 50(3), 287\u2013290.","journal-title":"Pharmacological Research"},{"issue":"51","key":"2995_CR49","doi-asserted-by":"publisher","first-page":"40134","DOI":"10.1074\/jbc.M003531200","volume":"275","author":"S Dhakshinamoorthy","year":"2000","unstructured":"Dhakshinamoorthy, S., & Jaiswal, A. K. (2000). Small maf (Maf G and Maf K) proteins negatively regulate antioxidant response element-mediated expression and antioxidant induction of the NAD(P)H: quinone oxidoreductase1 gene. The Journal of Biological Chemistry, 275(51), 40134\u201340141.","journal-title":"The Journal of Biological Chemistry"},{"issue":"1\u20132","key":"2995_CR50","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.mrfmmm.2004.06.041","volume":"555","author":"MK Kwak","year":"2004","unstructured":"Kwak, M. K., Wakabayashi, N., & Kensler, T. W. (2004). Chemoprevention through the Keap1\u2013Nrf2 signaling pathway by phase 2 enzyme inducers. Mutation Research, 555(1\u20132), 133\u2013148.","journal-title":"Mutation Research"},{"issue":"11-12","key":"2995_CR51","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1089\/ars.2005.7.1664","volume":"7","author":"KW Kang","year":"2005","unstructured":"Kang, K. W., Lee, S. J., & Kim, S. G. (2005). Molecular mechanism of Nrf2 activation by oxidative stress. Antioxidants & Redox Signaling, 7(11-12), 1664\u20131673.","journal-title":"Antioxidants & Redox Signaling"},{"issue":"3","key":"2995_CR52","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1124\/jpet.110.175828","volume":"337","author":"HJ Kim","year":"2011","unstructured":"Kim, H. J., Sato, T., Rodr\u00edguez-Iturbe, B., & Vaziri, N. D. (2011). Role of intrarenal angiotensin system activation, oxidative stress, inflammation, and impaired nuclear factor-erythroid-2-related factor 2 activity in the progression of focal glomerulosclerosis. The Journal of Pharmacology and Experimental Therapeutics, 337(3), 583\u2013590.","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"2995_CR53","first-page":"131","volume":"34","author":"DC Almeida de","year":"2013","unstructured":"de Almeida, D. C., Oliveira, C. D., Barbosa-Costa, P., & Origassa, S. T. C. (2013). In search of mechanisms associated with mesenchymal stem cell-based therapies for acute kidney injury. Clinical Biochemist Reviews, 34, 131\u2013144.","journal-title":"Clinical Biochemist Reviews"},{"issue":"2","key":"2995_CR54","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1159\/000319366","volume":"86","author":"W Zhuo","year":"2011","unstructured":"Zhuo, W., Liao, L., Xu, T., Wu, W., Yang, S., & Tan, J. (2011). Mesenchymal stem cells ameliorate ischemia-reperfusion-induced renal dysfunction by improving the antioxidant\/oxidant balance in the ischemic kidney. Urologia Internationalis, 86(2), 191\u2013196.","journal-title":"Urologia Internationalis"},{"issue":"7\u20138","key":"2995_CR55","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.lfs.2010.06.014","volume":"87","author":"K Sahin","year":"2010","unstructured":"Sahin, K., Tuzcu, M., Gencoglu, H., Do\u011fukan, A. S., Timurkan, M., Sahin, N., Aslan, A. N., & Kucuk, O. (2010). Epigallocatechin-3gallate activates Nrf2\/HO-1 signaling pathway in cisplatin induced nephrotoxicity in rats. Life Sciences, 87(7\u20138), 240\u2013245.","journal-title":"Life Sciences"},{"issue":"2","key":"2995_CR56","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/j.1523-1755.2005.67102.x","volume":"67","author":"SK Jo","year":"2005","unstructured":"Jo, S. K., Cho, W. Y., Sung, S. A., Kim, H. K., & Won, N. H. (2005). MEK inhibitor, U0126, attenuates cisplatin-induced renal injury by decreasing inflammation and apoptosis. Kidney International, 67(2), 458\u2013466.","journal-title":"Kidney International"},{"issue":"1","key":"2995_CR57","doi-asserted-by":"publisher","first-page":"F166","DOI":"10.1152\/ajprenal.00401.2004","volume":"289","author":"G Ramesh","year":"2005","unstructured":"Ramesh, G., & Reeves, W. B. (2005). p38 MAP kinase inhibition ameliorates cisplatin nephrotoxicity in mice. American Journal of Physiology. Renal Physiology, 289(1), F166\u2013F174.","journal-title":"American Journal of Physiology. Renal Physiology"},{"issue":"5","key":"2995_CR58","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1046\/j.1523-1755.2003.00908.x","volume":"63","author":"H Liu","year":"2003","unstructured":"Liu, H., & Baliga, R. (2003). Cytochrome P450 2E1 null mice provide novel protection against cisplatin-induced nephrotoxicity and apoptosis. Kidney International, 63(5), 1687\u20131696.","journal-title":"Kidney International"},{"issue":"3","key":"2995_CR59","doi-asserted-by":"publisher","first-page":"F543","DOI":"10.1152\/ajprenal.00112.2004","volume":"287","author":"I Arany","year":"2004","unstructured":"Arany, I., Megyesi, J. K., Kaneto, H., Price, P. M., & Safirstein, R. L. (2004). Cisplatin-induced cell death is EGFR\/src\/ERK signaling dependent in mouse proximal tubule cells. American Journal of Physiology. Renal Physiology, 287(3), F543\u2013F549.","journal-title":"American Journal of Physiology. Renal Physiology"},{"key":"2995_CR60","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/srep42027","volume":"7","author":"K Suchal","year":"2017","unstructured":"Suchal, K., Malik, S., Khan, S. I., Malhotra, R. K., Goyal, S. N., Bhatia, J., et al. (2017). Protective effect of mangiferin on myocardial ischemia-reperfusion injury in streptozotocin-induced diabetic rats: role of AGE-RAGE\/MAPK pathways. Scientific Reports, 7, 420\u2013427.","journal-title":"Scientific Reports"},{"issue":"6","key":"2995_CR61","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1002\/biof.1301","volume":"42","author":"S Chowdhury","year":"2016","unstructured":"Chowdhury, S., Sinha, K., Banerjee, S., & Sil, P. C. (2016). Taurine protects cisplatin induced cardiotoxicity by modulating inflammatory and endoplasmic reticulum stress responses. Biofactors, 42(6), 647\u2013664.","journal-title":"Biofactors"},{"issue":"3","key":"2995_CR62","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1042\/bj3020897","volume":"302","author":"M Kracht","year":"1994","unstructured":"Kracht, M., Shiroo, M., Marshall, C. J., Hsuan, J. J., & Saklatvala, J. (1994). Interleukin-1 activates a novel protein kinase that phosphorylates the epidermal-growth-factor receptor peptide T669. Biochem, 302(3), 897\u2013905.","journal-title":"Biochem"},{"issue":"Supplement A","key":"2995_CR63","first-page":"90","volume":"31","author":"R Hernanz","year":"2009","unstructured":"Hernanz, R., Beltran, A., P\u00e9rez-Gir\u00f3n, J. V., Mart\u00edn, A., Briones, A., Palacios, R., Salaices, M., & Alonso, M. J. (2009). Activation of p38 and ERK1\/2 MAPK by superoxide anion participates in angiotensin II-induced COX-2 expression in smooth muscle cells from resistance arteries. Methods and Findings in Experimental and Clinical Pharmacology, 31(Supplement A), 90\u2013153.","journal-title":"Methods and Findings in Experimental and Clinical Pharmacology"},{"issue":"11","key":"2995_CR64","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1111\/j.1600-0625.2009.00880.x","volume":"18","author":"GY Zhang","year":"2009","unstructured":"Zhang, G. Y., Li, X., Yi, C. G., Pan, H., He, G. D., Yu, Q., Jiang, L. F., Xu, W. H., Li, Z. J., Ding, J., Lin, D. S., & Gao, W. Y. (2009). Angiotensin II activates connective tissue growth factor and induces extracellular matrix changes involving Smad\/activation and p38 mitogen-activated protein kinase signaling pathways in human dermal fibroblasts. Experimental Dermatology, 18(11), 947\u2013953.","journal-title":"Experimental Dermatology"},{"issue":"2","key":"2995_CR65","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1006\/bbrc.1999.0759","volume":"259","author":"AS Lal","year":"1999","unstructured":"Lal, A. S., Clifton, A. D., Rouse, J., Segal, A. W., & Cohen, P. (1999). Activation of the neutrophil NADPH oxidase is inhibited by SB 203580, a specific inhibitor of SAPK2\/p38. Biochemical and Biophysical Research Communications, 259(2), 465\u2013470.","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"8","key":"2995_CR66","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1161\/01.RES.0000185804.79157.C0","volume":"97","author":"SH Chan","year":"2005","unstructured":"Chan, S. H., Hsu, K. S., Huang, C. C., Wang, L. L., Ou, C. C., & Chan, J. Y. (2005). NADPH oxidase-derived superoxide anion mediates angiotensin II-induced pressor effect via activation of p38 mitogen-activated protein kinase in the rostral ventrolateral medulla. Circulation Research, 97(8), 772\u2013780.","journal-title":"Circulation Research"},{"issue":"3","key":"2995_CR67","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/kisup.2011.21","volume":"1","author":"B Imberti","year":"2011","unstructured":"Imberti, B., Morigi, M., & Benigni, A. (2011). Potential of mesenchymal stem cells in the repair of tubular injury. Kidney International. Supplement, 1(3), 90\u201393.","journal-title":"Kidney International. Supplement"},{"issue":"7","key":"2995_CR68","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1053\/j.gastro.2008.03.015","volume":"134","author":"TK Kuo","year":"2008","unstructured":"Kuo, T. K., Hung, S. P., Chuang, C. H., Chen, C. T., Shih, Y. R. V., Fang, S. C. Y., Yang, V. W., & Lee, O. K. (2008). Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells. Gastroenterology, 134(7), 2111\u20132121.","journal-title":"Gastroenterology"},{"issue":"5","key":"2995_CR69","doi-asserted-by":"publisher","first-page":"e10493","DOI":"10.1371\/journal.pone.0010493","volume":"5","author":"DR Bhandari","year":"2010","unstructured":"Bhandari, D. R., Kwang-Won, S., Kyoung-Hwan Roh, R., Ji-Won, J., Soo-Kyung, K., & Kyung-Sun Kang, K. (2010). REX-1 expression and p38 MAPK activation status can determine proliferation\/differentiation fates in human mesenchymal stem cells. PLoS One, 5(5), e10493.","journal-title":"PLoS One"},{"issue":"6","key":"2995_CR70","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S0968-0004(00)01595-4","volume":"25","author":"AR Nebreda","year":"2000","unstructured":"Nebreda, A. R., & Porras, A. (2000). p38 MAP kinases: beyond the stress response. Trends in Biochemical Sciences, 25(6), 257\u2013260.","journal-title":"Trends in Biochemical Sciences"},{"issue":"1","key":"2995_CR71","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/sj.cr.7290257","volume":"15","author":"T Zarubin","year":"2005","unstructured":"Zarubin, T., & Han, J. (2005). Activation and signaling of the p38 MAP kinase pathway. Cell Research, 15(1), 11\u201318.","journal-title":"Cell Research"},{"key":"2995_CR72","first-page":"2095","volume":"54","author":"S Haldar","year":"1994","unstructured":"Haldar, S., Negrini, M., Monne, M., Sabbioni, S., & Croce, C. M. (1994). Down-regulation of bcl-2 by p53 in breast cancer cells. Cancer Research, 54, 2095\u20132097.","journal-title":"Cancer Research"},{"key":"2995_CR73","first-page":"1055","volume":"12","author":"A Thomas","year":"1996","unstructured":"Thomas, A., Rouby, S. E., Reed, J. C., Stanislaw, K., Silber, R., Potmesil, M., & Newcomb, E. W. (1996). Drug-induced apoptosis in B-cell chronic lymphocytic leukemia: relationship between p53 gene mutation and bcl-2\/bax proteins in drug resistance. Oncogene, 12, 1055\u20131062.","journal-title":"Oncogene"},{"issue":"21","key":"2995_CR74","doi-asserted-by":"publisher","first-page":"6027","DOI":"10.1093\/emboj\/18.21.6027","volume":"18","author":"PF Li","year":"1999","unstructured":"Li, P. F., Dietz, R., & Von Harsdorf, R. (1999). p53 regulates mitochondrial membrane potential through reactive oxygen species and induces cytochrome c-independent apoptosis blocked by Bcl-2. The EMBO Journal, 18(21), 6027\u20136036.","journal-title":"The EMBO Journal"},{"issue":"4","key":"2995_CR75","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1211\/jpp.61.04.0013","volume":"61","author":"J Xu","year":"2009","unstructured":"Xu, J., Xiong-wen, L., Huanga, Y., Zhua, P., & Lia, J. (2009). Synergism of simvastatin with losartan prevents angiotensin II-induced cardiomyocyte apoptosis in vitro. JPP, 61(4), 503\u2013510.","journal-title":"JPP"},{"issue":"5","key":"2995_CR76","doi-asserted-by":"publisher","first-page":"H2313","DOI":"10.1152\/ajpheart.1997.272.5.H2313","volume":"272","author":"Z Li","year":"1997","unstructured":"Li, Z., Bing, O. H., Long, X., Robinson, K. G., & Lakatta, E. G. (1997). Increased cardiomyocyte apoptosis during the transition to heart failure in the spontaneously hypertensive rat. American Journal of Physiology. Heart and Circulatory Physiology, 272(5), H2313\u2013H2319.","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"issue":"9","key":"2995_CR77","doi-asserted-by":"publisher","first-page":"F1141","DOI":"10.1152\/ajprenal.00060.2011","volume":"302","author":"JH Kim","year":"2012","unstructured":"Kim, J. H., Park, D. J., Yun, J. C., Jung, M. H., Yeo, H. D., Kim, H. J., Kim, D. W., Yang, J. I., Lee, G. W., Jeong, S. H., Roh, G. S., & Chang, S. H. (2012). Human adipose tissue-derived mesenchymal stem cells protect kidneys from cisplatin nephrotoxicity in rats. American Journal of Physiology. Renal Physiology, 302(9), F1141\u2013F1150.","journal-title":"American Journal of Physiology. Renal Physiology"},{"issue":"2","key":"2995_CR78","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1111\/j.1523-1755.2004.761_5.x","volume":"66","author":"BA Molitoris","year":"2004","unstructured":"Molitoris, B. A., & Sutton, T. A. (2004). Endothelial injury and dysfunction: role in the extension phase of acute renal failure. Kidney International, 66(2), 496\u2013499.","journal-title":"Kidney International"},{"key":"2995_CR79","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1152\/ajprenal.00050.2001","volume":"281","author":"DP Basile","year":"2001","unstructured":"Basile, D. P., Donohoe, D., Roethe, K., & Osborn, J. A. L. (2001). Renal ischemic injury results in permanent damage to peritubular capillaries and influences long-term function. American Journal of Physiology. Renal Physiology, 281, 887\u2013899.","journal-title":"American Journal of Physiology. Renal Physiology"},{"issue":"4","key":"2995_CR80","doi-asserted-by":"publisher","first-page":"F928","DOI":"10.1152\/ajprenal.00596.2007","volume":"294","author":"DP Basile","year":"2008","unstructured":"Basile, D. P., Fredrich, K., Chelladurai, B., Leonard, E. C., & Parrish, A. R. (2008). Renal ischemia reperfusion inhibits VEGF expression and induces ADAMTS-1, a novel VEGF inhibitor. American Journal of Physiology. Renal Physiology, 294(4), F928\u2013F936.","journal-title":"American Journal of Physiology. Renal Physiology"},{"issue":"1","key":"2995_CR81","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.bbrc.2007.04.083","volume":"358","author":"XS Zhong","year":"2007","unstructured":"Zhong, X. S., Liu, L. Z., Skinner, H. D., Cao, Z., Ding, M., & Jiang, B. H. (2007). Mechanism of vascular endothelial growth factor expression mediated by cisplatin in human ovarian cancer cells. Biochemical and Biophysical Research Communications, 358(1), 92\u201398.","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"9","key":"2995_CR82","doi-asserted-by":"publisher","first-page":"4604","DOI":"10.1128\/MCB.16.9.4604","volume":"16","author":"JA Forsythe","year":"1996","unstructured":"Forsythe, J. A., Jiang, B., Iyer, N. V., Agani, F., Leung, S. W., Koos, R. D., & Semenza, G. L. (1996). Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Molecular and Cellular Biology, 16(9), 4604\u20134613.","journal-title":"Molecular and Cellular Biology"},{"key":"2995_CR83","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1681\/ASN.V124822","volume":"12","author":"P I\u0148igo","year":"2001","unstructured":"I\u0148igo, P., Campistol, J. M., Lario, S., Piera, C., Campos, P., Oppenheimer, F., & Rivera, F. (2001). Effects of losartan and amlodipine on intrarenal hemodynamics and TGF \u03b2 1 plasma levels in a crossover trial in renal transplant recipients. Journal of the American Society of Nephrology, 12, 822\u2013827.","journal-title":"Journal of the American Society of Nephrology"},{"issue":"1","key":"2995_CR84","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0167-4889(00)00040-9","volume":"1497","author":"CC Chua","year":"2000","unstructured":"Chua, C. C., Hamdy, R. C., & Chua, B. H. L. (2000). Mechanism of transforming growth factor-L1-induced expression of vascular endothelial growth factor in murine osteoblastic MC3T3-E1 cells. Biochimica et Biophysica Acta, 1497(1), 69\u201376.","journal-title":"Biochimica et Biophysica Acta"},{"issue":"7","key":"2995_CR85","doi-asserted-by":"publisher","first-page":"3877","DOI":"10.1074\/jbc.271.7.3877","volume":"271","author":"DT Shima","year":"1996","unstructured":"Shima, D. T., Kuroki, M., Deutsch, U., Ng, Y. S., Adamis, A. P., & D\u2019Amore, P. A. (1996). The mouse gene for vascular endothelial growth factor: genomic structure, definition of the transcriptional unit, and characterization of transcriptional and post-transcriptional regulatory sequences. The Journal of Biological Chemistry, 271(7), 3877\u20133883.","journal-title":"The Journal of Biological Chemistry"},{"key":"2995_CR86","first-page":"109","volume":"1","author":"MT Abdel Aziz","year":"2011","unstructured":"Abdel Aziz, M. T., Wassef, M. A., Rashed, L. A., Mhfouz, S., & Omar, N. (2011). Mesenchymal stem cells therapy in acute renal failure: possible role of hepatocyte growth factor. Journal of Stem Cell Research and Therapy, 1, 109.","journal-title":"Journal of Stem Cell Research and Therapy"},{"issue":"5","key":"2995_CR87","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1111\/j.1582-4934.2007.00120.x","volume":"11","author":"SG Ball","year":"2007","unstructured":"Ball, S. G., Shuttleworth, C. A., & Kielty, C. M. (2007). Mesenchymal stem cells and neovascularization: role of platelet derived growth factor receptors. Journal of Cellular and Molecular Medicine, 11(5), 1012\u20131030.","journal-title":"Journal of Cellular and Molecular Medicine"},{"issue":"10","key":"2995_CR88","doi-asserted-by":"publisher","first-page":"2648","DOI":"10.1634\/stemcells.2007-0226","volume":"25","author":"Y Wu","year":"2007","unstructured":"Wu, Y., Chen, L., Scott, P. G., & Tredget, E. E. (2007). Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Stem Cells, 25(10), 2648\u20132659.","journal-title":"Stem Cells"},{"issue":"3","key":"2995_CR89","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1097\/00041552-200205000-00006","volume":"11","author":"R Bonegio","year":"2002","unstructured":"Bonegio, R., & Lieberthal, W. (2002). Role of apoptosis in the pathogenesis of acute renal failure. Current Opinion in Nephrology and Hypertension, 11(3), 301\u2013308.","journal-title":"Current Opinion in Nephrology and Hypertension"},{"issue":"1","key":"2995_CR90","first-page":"58","volume":"41","author":"A Shirwaikar","year":"2003","unstructured":"Shirwaikar, A., Malini, S., & Kumari, S. C. (2003). Protective effect of Pongamia pinnata flowers against cisplatin and gentamicin induced nephrotoxocity in rats. Indian Journal of Experimental Biology, 41(1), 58\u201362.","journal-title":"Indian Journal of Experimental Biology"},{"key":"2995_CR91","first-page":"47","volume":"1","author":"MH Hanigan","year":"2003","unstructured":"Hanigan, M. H., & Devaranjan, P. (2003). Cisplaitn nephrotoxicity: molecular mechanisms. Cancer Therapy, 1, 47\u201361.","journal-title":"Cancer Therapy"},{"issue":"1","key":"2995_CR92","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/ki.2011.120","volume":"80","author":"A Havasi","year":"2011","unstructured":"Havasi, A., & Borkan, S. C. (2011). Apoptosis and acute kidney injury. Kidney International, 80(1), 29\u201340.","journal-title":"Kidney International"},{"issue":"4","key":"2995_CR93","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1093\/ndt\/gfn596","volume":"24","author":"N Mihailovi\u0107-Stanojevi\u0107","year":"2009","unstructured":"Mihailovi\u0107-Stanojevi\u0107, N., Jovovi\u0107, D., Miloradovi\u0107, Z., Gruji\u0107-Milanovi\u0107, J., Jerki\u0107, M., & Markovi\u0107-Lipkovski, J. (2009). Reduced progression of adriamycin nephropathy in spontaneously hypertensive rats treated by losartan. Nephrology, Dialysis, Transplantation, 24(4), 1142\u20131150.","journal-title":"Nephrology, Dialysis, Transplantation"},{"key":"2995_CR94","first-page":"963","volume":"31","author":"Z Chen","year":"2012","unstructured":"Chen, Z., Zhu, L., Zhen, Y., Li, D., Tang, B., Chen, W., & Hu, L. (2012). Anti-proteinuric effect of sulodexide in adriamycin-induced nephropathy rats. Latin American Journal of Pharmacy, 31, 963\u2013967.","journal-title":"Latin American Journal of Pharmacy"},{"issue":"5","key":"2995_CR95","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1111\/j.1523-1755.2005.00275.x","volume":"67","author":"F T\u00f6gel","year":"2005","unstructured":"T\u00f6gel, F., Isaac, J., Hu, Z. M., Weiss, K., & Westenfelder, C. (2005). Renal SDF-1 signals mobilization and homing of CXCR4-positive cells to the kidney after ischemic injury. Kidney International, 67(5), 1772\u20131784.","journal-title":"Kidney International"},{"issue":"11","key":"2995_CR96","first-page":"1","volume":"2","author":"Y Li","year":"2013","unstructured":"Li, Y., & Wingert, R. A. (2013). Regenerative medicine for the kidney: stem cell prospects and challenges. Clinical and Translational Medicine, 2(11), 1\u201316.","journal-title":"Clinical and Translational Medicine"},{"issue":"1","key":"2995_CR97","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13287-015-0066-5","volume":"6","author":"C Li","year":"2015","unstructured":"Li, C., Wu, X., Tong, J., Yang, X., Zhao, J., Zheng, Q., Zhao, G., & Ma, Z. (2015). Comparative analysis of human mesenchymal stem cells from bone marrow and adipose tissue under xeno-free conditions for cell therapy. Stem Cell Research & Therapy, 6(1), 55.","journal-title":"Stem Cell Research & Therapy"}],"container-title":["Applied Biochemistry and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-019-02995-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12010-019-02995-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-019-02995-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T20:24:26Z","timestamp":1663273466000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12010-019-02995-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,12]]},"references-count":97,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["2995"],"URL":"https:\/\/doi.org\/10.1007\/s12010-019-02995-2","relation":{},"ISSN":["0273-2289","1559-0291"],"issn-type":[{"value":"0273-2289","type":"print"},{"value":"1559-0291","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,12]]},"assertion":[{"value":"4 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All experiments were performed in accordance with the National Institutes of Health guidelines and with approval from the Institutional Animal Care and Use Committee, National Research Centre, Egypt.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}